What Will Happen to AURORA CANNABIS INC ORDINARY SHARES (OTCMKTS:ACBFF) Next? The Stock Has Increase in Shorts

June 16, 2018 - By Richard Conner

Aurora Cannabis Inc. (OTCMKTS:ACBFF) Logo

The stock of AURORA CANNABIS INC ORDINARY SHARES (OTCMKTS:ACBFF) registered an increase of 24.57% in short interest. ACBFF’s total short interest was 28.85 million shares in June as published by FINRA. Its up 24.57% from 23.16M shares, reported previously. With 2.51 million shares average volume, it will take short sellers 12 days to cover their ACBFF’s short positions. The short interest to AURORA CANNABIS INC ORDINARY SHARES’s float is 8.35%.

The stock increased 0.29% or $0.02 during the last trading session, reaching $6.86. About 854,922 shares traded. Aurora Cannabis Inc. (OTCMKTS:ACBFF) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500.

Aurora Cannabis Inc., together with its subsidiaries, produces and distributes medical marijuana products in Canada. The company has market cap of $3.88 billion. The companyÂ’s products consist of dried cannabis and cannabis oil. It currently has negative earnings.

More notable recent Aurora Cannabis Inc. (OTCMKTS:ACBFF) news were published by: Seekingalpha.com which released: “Canada poised to approve marijuana sales” on June 07, 2018, also Profitconfidential.com with their article: “Marijuana Stocks: Why I Would Choose Aurora Stock at Any Point in Time” published on May 28, 2018, Profitconfidential.com published: “Marijuana News Today: Several Big-Name Pot Companies Top Short-Seller List” on June 15, 2018. More interesting news about Aurora Cannabis Inc. (OTCMKTS:ACBFF) were released by: Profitconfidential.com and their article: “Why the Aurora-MedReleaf Acquisition Didn’t Help ACBFF Stock…Yet” published on May 18, 2018 as well as Seekingalpha.com‘s news article titled: “Aurora Cannabis Is Compelling Over The Long Term” with publication date: June 12, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: